English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 28 March 2018, 19:13 JST
Share:
    

Source: Mitsubishi Corporation
Mitsubishi Corporation and Hogy Medical Form Comprehensive Alliance

TOKYO, Mar 28, 2018 - (JCN Newswire) - Hogy Medical Company Limited and Mitsubishi Corporation (MC) hereby announce that they have entered into a comprehensive business alliance in the medical business field.

The domestic business environment poses a severe challenge for hospitals in Japan in light of the country's aging population and rising medical costs. Meanwhile, overseas markets where demand for new medical services continues to increase show tremendous potential for growth.

While Hogy Medical has been developing products that contribute to the safety of patients and healthcare staff and to the improvement of hospital management since its establishment in 1961, MC has built up an extensive network, both domestically and abroad, over many years and has amassed a wealth of experience engaging with diverse sectors in overseas markets. Given that backdrop, both partners felt that there is much to gain in terms of mutual benefit should they pool the knowledge and individual strengths that they have cultivated to develop a new medical consumables and services business.

The alliance will focus on the following three areas as both companies seek to meet changing demands.

1. Developing Business for Medical Consumables in Overseas Markets
Expand and open up new markets for Hogy brand products, including potentially establishing a joint venture; identify companies from which to procure kit products; and create alliances with medical consumables manufacturers for the purpose of manufacturing new products.

2. Establishing Business for Reprocessing of Single Use Devices (SUD)
Explore the possibilities for establishing SUD reprocessing* business in the areas of manufacturing, distribution, collection, and sales, in light of projections that the demand for SUD reprocessing is expected to increase in Japan due to its cost advantage and effective resource utilization as well as its positive impact on environmental conservation.

*SUD Reprocessing refers to the collection, testing, disassembling, decontamination, and sterilization of used Single Use Devices (SUD) and reprocessing them into SUDs that can be resold for the same purpose as their original use. Japan's Ministry of Health established new regulations for the reprocessing business on July 31, 2017.

3. Developing Next Generation Management Support Solutions for Acute Care Hospitals
Draw on the customer base and know-how established and cultivated by both companies to develop new generation management support solutions that will contribute to improving the management of the whole supply chain at acute care hospitals.

Contact:
Mitsubishi Corporation
Telephone:+81-3-3210-2171
Facsimile:+81-3-5252-7705


Topic: Press release summary
Source: Mitsubishi Corporation

Sectors: BioTech, Engineering
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
Mitsubishi Corporation Links

http://www.mitsubishicorp.com

https://www.linkedin.com/company/mitsubishi-corporation/

Mitsubishi Corporation Related News
Thursday, 4 July 2024, 17:33 JST
World's first* supply chain established for more sustainable polyester fiber based on CO2-derived material as well as renewable and bio-based materials
Tuesday, 18 June 2024, 11:21 JST
Joint Study on the Social Implementation of Hydrogen and Decarbonized Fuels
Monday, 17 June 2024, 16:36 JST
Joint Discussions on Green Hydrogen Supply in Hokkaido's Chitose Area
Thursday, 13 June 2024, 17:18 JST
Honda and MC to Establish New Company, ALTNA Co., Ltd.
Tuesday, 30 April 2024, 19:08 JST
Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575